FIELD: medicine.
SUBSTANCE: cardiac recipient's blood plasma placental growth factor (P1GF) is measured prior to grafting and within 24 to 36 months after grafting. If observing the P1GF level increased more than by 60% of the pre-grafting values, the development of irreversible graft dysfunction is predicted.
EFFECT: it is possible to predict the remote development of irreversible graft dysfunction in the recipients after cardiac graft surgeries.
3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREDICTION OF PREVALENCE OF STENOTIC TRANSPLANT CORONARY BED LESION IN RECIPIENTS FOLLOWING CARDIAC TRANSPLANTATION | 2010 |
|
RU2426124C1 |
| METHOD FOR PREDICTION OF REMOTE RESULT OF KIDNEY TRANSPLANTATION | 2024 |
|
RU2841552C1 |
| METHOD OF SCREENING DIAGNOSTICS OF ACUTE CELLULAR REJECTION OF TRANSPLANTED HEART | 2016 |
|
RU2614726C1 |
| METHOD FOR PREOPERATIVE PREDICTION OF ACUTE CELLULAR REJECTION OF A TRANSPLANTED HEART | 2022 |
|
RU2798948C1 |
| METHOD FOR DIAGNOSING ACUTE GRAFT REJECTION IN HEART RECIPIENTS | 2021 |
|
RU2759049C1 |
| METHOD FOR NON-INVASIVE DIAGNOSIS OF MYOCARDIAL FIBROSIS OF TRANSPLANTED HEART AT A LONG POST-TRANSPLANTATION PERIOD IN RECIPIENTS SUFFERING ACUTE REJECTION | 2019 |
|
RU2709193C1 |
| METHOD FOR NON-INVASIVE DIAGNOSIS OF MYOCARDIAL FIBROSIS IN CARDIAC TRANSPLANT RECIPIENTS | 2021 |
|
RU2760093C1 |
| METHOD FOR NON-INVASIVE DIAGNOSIS OF MYOCARDIAL FIBROSIS IN TRANSPLANTED HEART | 2021 |
|
RU2758993C1 |
| SCREENING DIAGNOSIS METHOD OF ACUTE CELLULAR REJECTION OF TRANSPLANTED HEART | 2015 |
|
RU2618404C1 |
| METHOD FOR NON-INVASIVE DIAGNOSIS OF MYOCARDIAL FIBROSIS IN DONOR HEART RECIPIENTS | 2021 |
|
RU2761470C1 |
